Human lymph-node CD8(+) T cells display an altered phenotype during systemic autoimmunity.

Area of Science:

• Immunology
• Autoimmunity
• Rheumatoid Arthritis Research

Background:

• The role of CD8(+) T cells in autoimmunity remains unclear, despite extensive research on CD4(+) T cells.
• Understanding CD8(+) T cell function is crucial for developing targeted therapies for autoimmune diseases.

Purpose of the Study:

• To investigate the phenotype and function of CD8(+) T cells during the early stages of rheumatoid arthritis (RA).
• To identify potential biomarkers for early autoimmune disease detection and progression.

Main Methods:

• Analysis of CD8(+) T cells from human lymph-node biopsies and peripheral blood in early RA patients.
• Phenotypic characterization using flow cytometry, including CD69, IL-17A, and IL-10 expression.
• Correlation of immune cell profiles with disease activity.

Main Results:

• Pro-inflammatory CD8(+) T cells in lymphoid tissue showed a less-responsive phenotype in early RA.
• Increased CD8(+) memory T cells and recently activated CD8(+) T cells (CD69(+)) were observed in lymphoid tissue and peripheral blood before clinical RA onset.
• Reduced IL-17A production by CD8(+) T cells and decreased frequency of regulatory CD8(+) T cells (IL-10(+)) correlated with disease activity.

Conclusions:

• CD8(+) T cell subsets are significantly affected during the earliest phases of systemic autoimmunity, even before the clinical onset of RA.
• These alterations in CD8(+) T cell populations may play a role in the pathogenesis of RA.
• Findings suggest potential for CD8(+) T cells as early indicators or therapeutic targets in RA.